Charles River Laboratories International, Inc. 提供产品和服务,以帮助制药和生物技术公司。公司总部位于马萨诸塞州威尔明顿,目前拥有18600名全职员工。公司于2000年6月23日上市。公司提供必要的产品和服务,以帮助全球制药和生物技术公司、政府机构和学术机构加速其研究和药物开发工作。其研究模型和服务部门包括三个业务部门,提供基础工具,帮助客户发现新的分子:研究模型、研究模型服务和细胞解决方案。其发现与安全评估部门提供受监管和非监管的DSA服务,支持潜在新药的研究、开发及法规要求的安全性测试,包括治疗发现与优化以及体外和体内研究、实验室支持服务,以及战略非临床咨询和项目管理,以支持产品开发。其制造解决方案部门包括微生物解决方案和生物制剂解决方案。
What is Charles River Laboratories International Inc (CRL)'s P/E Ratio?
The P/E ratio of Charles River Laboratories International Inc is 895.4568
Who is the CEO of Charles River Laboratories International Inc?
Mr. James Foster is the Chairman of the Board of Charles River Laboratories International Inc, joining the firm since 1976.
What is the price performance of CRL stock?
The current price of CRL is $290, it has 下降 0.49% in the last trading day.
What are the primary business themes or industries for Charles River Laboratories International Inc?
Charles River Laboratories International Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Charles River Laboratories International Inc market cap?
Charles River Laboratories International Inc's current market cap is $13.9B
Is Charles River Laboratories International Inc a buy, sell, or hold?
According to wall street analysts, 18 analysts have made analyst ratings for Charles River Laboratories International Inc, including 2 strong buy, 7 buy, 14 hold, 0 sell, and 2 strong sell